Richard Mason
Vorstandsvorsitzender bei Phoqus Pharmaceuticals Plc
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Neel Varshney | M | - |
Apollo Therapeutics Group Ltd.
 Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason.
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | - |
| Jim Momtazee | M | - |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason.
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | 3 Jahre |
| Ian Tomlinson | M | - |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason.
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | - |
| Laura Furmanski | F | - |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason.
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason. | - |
| Vasundhara Bhargava | F | - |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason.
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | 3 Jahre |
| James Momtazee | M | 52 |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | - |
| Magnus Jaderberg | M | - |
The Royal College of Physicians
| - |
| Suyash Prasad | M | 54 |
The Royal College of Physicians
| - |
| Vincent O'Neill | M | 55 |
The Royal College of Physicians
| - |
| Kei Siong Khoo | M | 62 |
The Royal College of Physicians
| - |
| Peng Tiam Ang | M | 65 |
The Royal College of Physicians
| - |
| Andrew Richard Rut | M | 63 |
The Royal College of Physicians
| - |
| Richard Bryce | M | 66 |
The Royal College of Physicians
| - |
| Matt Gysler | M | - |
The Royal College of Physicians
| - |
| Ashish Soman | M | - |
The Royal College of Physicians
| - |
| Kevin Chen | M | - |
The Royal College of Physicians
| - |
| Brian John O’Keeffe | M | - |
The Royal College of Physicians
| - |
| Curt Mikael von Euler-Chelpin | M | 71 |
The Royal College of Physicians
| - |
| Tong Choon Cheo | M | 78 |
The Royal College of Physicians
| - |
| Olor'ogun Sonny Folorunso Kuku | M | 80 |
The Royal College of Physicians
| - |
| David J. Clark | M | 59 |
The Royal College of Physicians
| - |
| Charles Q. Morris | M | 59 |
The Royal College of Physicians
| - |
| Michael Burgess | M | 61 |
The Royal College of Physicians
| - |
| Athasit Vejjajiva | M | 88 |
The Royal College of Physicians
| - |
| Chee Siong Soo | M | 63 |
The Royal College of Physicians
| - |
| Pyarelal Baburam Tiwari | M | 77 |
The Royal College of Physicians
| - |
| Seng Weng Wong | M | - |
The Royal College of Physicians
| - |
| Rupert Vessey | M | 59 |
The Royal College of Physicians
| - |
| Lik Yuen Chan | M | 55 |
The Royal College of Physicians
| 29 Jahre |
| Ian Gourley | M | - |
The Royal College of Physicians
| - |
| Mark White | M | 57 |
The Royal College of Physicians
| - |
| Christopher Burton | M | - |
The Royal College of Physicians
| - |
| Sam Williams | M | - |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason. | - |
| Huck Joo Tan | M | 56 |
The Royal College of Physicians
| 27 Jahre |
| Arvind Balakrishna Kasaragod | M | - |
The Royal College of Physicians
| - |
| Ash Soman | M | - |
The Royal College of Physicians
| - |
| Bipin Mistry | M | - |
The Royal College of Physicians
| - |
| Vasundhara Bhargava | F | - |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | - |
| Ravi Rao | M | 55 |
The Royal College of Physicians
| - |
| Alexander Macrae | M | 61 |
The Royal College of Physicians
| - |
| Edwin Tucker | M | 52 |
The Royal College of Physicians
| - |
| Dominic Smethurst | M | 50 |
The Royal College of Physicians
| - |
| Omar Khwaja | M | 54 |
The Royal College of Physicians
| 25 Jahre |
| Chun Kwan Chow | M | 69 |
The Royal College of Physicians
| 39 Jahre |
| Wai Ming Lam | M | 66 |
The Royal College of Physicians
| 35 Jahre |
| John Cullity | M | - |
The Royal College of Physicians
| - |
| Ka Shing Yan | M | 38 |
The Royal College of Physicians
| - |
| Zaki Morad bin Mohamad Zaher | M | 74 |
The Royal College of Physicians
| - |
| Siew Mun Chu | M | 81 |
The Royal College of Physicians
| 50 Jahre |
| Suan Yew Lee | M | 91 |
The Royal College of Physicians
| - |
| Rudolf Kwan | M | 71 |
The Royal College of Physicians
| - |
| Michael McDonald | M | - |
The Royal College of Physicians
| - |
| Herman Waldmann | M | - |
The Royal College of Physicians
| - |
| Edwin Graham Meek | M | 76 |
The Royal College of Physicians
| - |
| Peter Dewis | M | - |
The Royal College of Physicians
| - |
| Hamish Alan Cameron | M | 70 |
The Royal College of Physicians
| - |
| John Bonnar | M | - |
The Royal College of Physicians
| - |
| John Anderson | M | - |
The Royal College of Physicians
| - |
| Richard Fuller | M | - |
The Royal College of Physicians
| - |
| Ka Wah Hui | M | 60 |
The Royal College of Physicians
| - |
| Patricia Smith | M | - |
The Royal College of Physicians
| 40 Jahre |
| David Shapiro | M | 69 |
The Royal College of Physicians
| - |
| Ken Cunningham Cunningham | M | 71 |
The Royal College of Physicians
| - |
| Richard Colin | M | - |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | - |
| Ik King Tiong | M | 74 |
The Royal College of Physicians
| 47 Jahre |
| Paul Blake | M | 76 |
The Royal College of Physicians
| - |
| Cheok Peng Lim | M | 77 |
The Royal College of Physicians
| 47 Jahre |
| Roger A. Perrault | M | 87 |
The Royal College of Physicians
| 44 Jahre |
| Yiu Nam Lau | M | 63 |
The Royal College of Physicians
| 37 Jahre |
| Helen Torley | M | 61 |
The Royal College of Physicians
| - |
| Freda Lewis-Hall | M | 69 |
The Royal College of Physicians
| - |
| Adam Craig | M | 58 |
The Royal College of Physicians
| - |
| Frank Armstrong | M | 67 |
The Royal College of Physicians
| 40 Jahre |
| Colin Broom | M | 68 |
The Royal College of Physicians
| - |
| Stephen L. Bandak | M | 74 |
The Royal College of Physicians
| 47 Jahre |
| Peter G Johnson | M | - |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | 24 Jahre |
| Peter Gardiner | M | - |
The Royal College of Physicians
| - |
| Simon Long | M | - |
The Royal College of Physicians
| - |
| Hilary McElwaine-Johnn | M | - |
The Royal College of Physicians
| - |
| Preetinder Singh Joshi | M | 75 |
The Royal College of Physicians
| 46 Jahre |
| Kim Chan Koh | M | - |
The Royal College of Physicians
| - |
| James Shannon | M | 68 |
The Royal College of Physicians
| - |
| Lewis J. Rubin | M | - |
The Royal College of Physicians
| - |
| Paul Kenna | M | - |
The Royal College of Physicians
| - |
| Akshay Vaishnaw | M | 61 |
The Royal College of Physicians
| - |
| Ramesh Kancharla | M | 63 |
The Royal College of Physicians
| - |
| Chrisantha Nicholas Nonis | M | - |
The Royal College of Physicians
| - |
| Caroline Dumas | M | - |
The Royal College of Physicians
| - |
| Stephen Lockhart | M | 67 |
The Royal College of Physicians
| 41 Jahre |
| Felicity Gabbay | M | 72 |
The Royal College of Physicians
| - |
| Alan Keith Boyd | M | 70 |
The Royal College of Physicians
| - |
| Samuel N. Marcus | M | - |
The Royal College of Physicians
| - |
| Emmet B. Keeffe | M | - |
The Royal College of Physicians
| - |
| Emiko Terasaki | M | - |
The Royal College of Physicians
| 25 Jahre |
| Swee Huat Phua | M | 70 |
The Royal College of Physicians
| - |
| Michel Grandjean | M | - |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | 16 Jahre |
| Mehmood Khan | M | 66 |
The Royal College of Physicians
| - |
| Dawn Viveash | M | 68 |
The Royal College of Physicians
| - |
| Leo Kearns | M | - |
The Royal College of Physicians
| - |
| Keng Hwang Teh | M | 71 |
The Royal College of Physicians
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Richard Mason
- Persönliches Netzwerk
